Methyl orange photo‐degradation by tio2 in a pilot unit under different chemical, physical, and hydraulic conditions

The photo‐catalytic degradation of a textile azo‐dye as Methyl Orange was studied in an innovative unit constituted by a channel over which a layer of titanium dioxide (TiO2) catalyst in anatase form was deposited and activated by UVB irradiation. The degradation kinetics were followed after variation of the chemical, physical, and hydraulic/hydrodynamic parameters of the system. For this purpose, the influence of the TiO2 dosage (g/cm3), dye concentration (mg/L), pH of the solution, flow‐rate (L/s), hydraulic load (cm), and irradiation power (W) were evaluated on the degradation rates. It was observed that the maximum dosage of TiO2 was 0.79 g/cm3 while for higher dosage a reduction of homogeneity of the cement conglomerate occurred. The Langmuir– Hinshelwood (LH) kinetic model was followed up to a dye concentration around 1 mg/L. It was observed that with the increase of the flow rate, an increase of the degradation kinetics was obtained, while the further increase of the flow‐rate associated with the modification of the hydraulic load determined a decrease of the kinetic rates. The results also evidenced an increase of the kinetic rates with the increase of the UVB intensity. A final comparison with other dyes such as Methyl Red and Methylene Blue was carried out in consideration of the pH of the solution, which sensibly affected the removal efficiencies

Early thromboelastography in acute traumatic coagulopathy: an observational study focusing on pre-hospital trauma care

Background: Major brain injury and uncontrolled blood loss remain the primary causes of early trauma-related mortality. One-quarter to one-third of trauma patients exhibit trauma-induced coagulopathy (TIC). Thromboelastometry (ROTEM) and thrombelastography (TEG) are valuable alternatives to standard coagulation testing, providing a more comprehensive overview of the coagulation process. Purpose: Evaluating thromboelastographic profile, the incidence of fibrinolysis (defined as Ly30 > 3%) in severe trauma patients, and factors influencing pathological coagulation pattern. Methods: Prospective observational 2\ua0years cohort study on severe trauma patients assisted by Helicopter Emergency Medical System (HEMS) and Level 1 Trauma Center, in a tertiary referral University Hospital. Results: Eighty three patients were enrolled, mean NISS (new injury severity score) 36 (\ub1 13). Mean R value decreased from 7.25 (\ub1 2.6) to 6.19 (\ub1 2.5) min (p 40 groups, changes in R value increased their significance (p = 0.04 and p < 0.03, respectively). Pathological TEG was found in 71 (88.8%) patients at T0 and 74 (92.5%) at T1. Hypercoagulation was present in 57 (71.3%) patients at T0, and in 66(82.5%) at T1. 9 (11.3%) patients had hyperfibrinolysis at T0, 7 (8.8%) patients at T1. Prevalence of StO2 < 75% at T0 was greater in patients whose TEG worsened (7 patients, 46.7%) against whose TEG remained stable or improved (8 patients, 17.4%) from T0 to T1 (p = 0.02). 48 (57.8%) patients received < 1000\ua0mL of fluids, while 35 (42.2%) received 65 1000\ua0mL. The first group had fewer patients with hypercoagulation (20, 41.6%) than the second (6, 17.6%) at T1 (p < 0.03). No differences were found for same TEG pattern at T0, nor other TEG pattern. Conclusion: Our population is representative of a non-hemorrhagic severe injury subgroup. Almost all of our trauma population had coagulation abnormalities immediately after the trauma; pro-coagulant changes were the most represented regardless of the severity of injury. NISS appears to affect only R parameter on TEG. Hyperfibrinolysis has been found in a low percentage of patients. Hypoperfusion parameters do not help to identify patients with ongoing coagulation impairment. Small volume resuscitation and mild hypotermia does not affect coagulation, at least in the early post-traumatic phase

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.

Since the beginning of the COVID-19 pandemic, concerns have been expressed worldwide for patients with hemoglobinopathies and their vulnerability to SARS-CoV-2 infection. Data from Lebanon confirmed a role of underlying comorbidities on COVID-19 severity, but no deaths among a cohort of thalassemia patients.1 Patients with sickle cell disease (SCD) displayed a broad range of severity after SARS-CoV-2 infection, spanning from a favorable outcome unless pre-existing comorbidities (UK cohort)2 to high case mortality in US.3 History of pain, heart, lung, and renal comorbidities was identified as risk factors of worse COVID-19 outcomes by the US SECURE-SCD Registry.4 While Italy experienced a death rate in the general population among the highest in the world, preliminary data from the first wave of the pandemic showed a lower than expected number of infected thalassemia patients (updated up to April 10, 2020), likely due to earlier and more vigilant self-isolation compared to the general population.

Treatments of asbestos containing wastes

Since the second half of the twentieth century, many studies have indicated inhalation of asbestos fibers as the main cause of deadly diseases including fibrosis and cancer. Consequently, since the beginning of the 80s, many countries started banning production and use of asbestos containing products (ACP), although still present in private and public buildings. Due to some extraordinary catastrophic events and/or the aging of these products, people's health and environmental risk associated with the inhalation of asbestos fibers keeps being high even in those countries where it was banned. For these reasons, many communities are developing plans for an environmental and sanitary safe asbestos removal and management. Asbestos containing wastes (ACW) are usually disposed in controlled landfills, but this practice does not definitively eliminate the problems related with asbestos fiber release and conflicts with the ideas of sustainable land use, recycling, and closing material cycles. Consequently, many scientific papers and patents proposed physical, chemical, and biological treatments aimed to the detoxification of ACW (or the reduction of their health effects) and looking for the adoption of technologies, which allow the reuse of the end-products. By including recent relevant bibliography, this report summarizes the status of the most important and innovative treatments of ACW, providing main operating parameters, advantages, and disadvantages

CHRONIC TOXICITY EFFECTS ON DAPHNIA MAGNA OF TREATED AQUEOUS SOLUTIONS OF IMIDAZOLE BASED COMPOUNDS BY UV/H2O2.

- Ionic liquids (ILs) are considered as an alternative to traditional industrial organic solvents. To date, there are no papers about their detenction in effluents and in surface water, and they have emerged as contaminants within the frame of the Horizon Program due to their high solubility in water and poor biodegrability. The present work investigated the photocatalytic degradation of four imidazole-based compounds (imidazole, 1-methylimidazole, 1-ethyl-3-methyl-imidazolium chloride and 1- butyl-3-methyl-imidazolium chloride) by means of UV254/H2O2 ad advanced oxidation process in a complex aqueous matrix from the outlet of a wastewater treatment plant. The degradation was compared to the previous investigated photodegradation in bidistilled water and a mathematical model was proposed considering the overall role of the different scavengers in the competition reactions with photogenerated •OH radicals. In addition, a chronic toxicity assay using the freshwater crustacean Daphnia magna was employed for evaluating the ecotoxicity of photocatalytically treated solutions. The results highlighted that the effects of untreated and treated solutions on D. magna survival decreased with increasing lipophilicity and that it was necessary a fourth generation of ILs by-products to reduce the long-term effects of treated solutions. Delayed reproductive maturity and reduced fecundity were found regardless of treatment